Default: Cancer Medicine

ISSN:

Journal Home

Journal Guideline

Cancer Medicine Q1 Unclaimed

John Wiley and Sons Inc United Kingdom
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Cancer Medicine is a journal indexed in SJR in Oncology and Cancer Research with an H index of 95. It is an CC BY Journal with a Single blind Peer Review review system, and It has a price of 2187 €. The scope of the journal is focused on cancer biology, cancer medicine, cancer prevention. It has an SJR impact factor of 1,201 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,201.

Cancer Medicine focuses its scope in these topics and keywords: cancer, cell, apoptosis, chronic, cohort, methylation, myeloid, patients, role, treatment, ...

Type: Journal

Type of Copyright: CC BY

Languages: English

Open Access Policy: Open Access

Type of publications:

Publication frecuency: -

Price

2187 €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

Cancer Medicine

1,201

SJR Impact factor

95

H Index

1116

Total Docs (Last Year)

3075

Total Docs (3 years)

48447

Total Refs

10414

Total Cites (3 years)

3057

Citable Docs (3 years)

3.16

Cites/Doc (2 years)

43.41

Ref/Doc

Comments

No comments ... Be the first to comment!

Aims and Scope


cancer, cell, apoptosis, chronic, cohort, methylation, myeloid, patients, role, treatment, advanced, affecting, alliancepredictors, andhermolecular, bcell, binding, biomarker, brain, breast, calgb, cancerevidence, cancerpersonality, carcinoma, carcinomaeffects, cdk, cells, cycle, databasebloodbased, determination, diagnosed, cancer biology, cancer medicine, cancer prevention

FAQS